학술논문

TRIAL OF RUCAPARIB IN PROSTATE INDICATIONS 2 (TRITON2): AN INTERNATIONAL, MULTICENTRE, OPEN-LABEL PHASE 2 STUDY OF THE PARP INHIBITOR RUCAPARIB IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) ASSOCIATED WITH HOMOLOGOUS RECOMBINATION DEFICIENCY (HRD)

Document Type

Journal

Author

Shapiro, Jeremy; Voskoboynik, Mark; Krieger, Laurence; Byard, Ian; Clay, Timothy; Ganju, Vinod; Abida, Wassim; Chowdhury, Simon; Watkins, Simon; Despain, Darrin; Simmons, Andy; Go, Jowell; Golsorkhi, Tony; Scher, Howard I.

Source

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY; JUL 2017, 13 p61-p61, 1p. Supplement: 1

Subject

Language

English

ISSN

17437563

Online Access

Full Text (Wiley Journals) Full Text (Wiley-DB) Web of Science JCR 저널정보 Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송